Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesspositive regulation of natural killer cell mediated cytotoxicity

STAT5A LAMP1

5.47e-054062GO:0045954
GeneOntologyBiologicalProcesspositive regulation of natural killer cell mediated immunity

STAT5A LAMP1

6.64e-054462GO:0002717
GeneOntologyBiologicalProcessregulation of natural killer cell mediated cytotoxicity

STAT5A LAMP1

1.99e-047662GO:0042269
GeneOntologyBiologicalProcesspositive regulation of leukocyte mediated cytotoxicity

STAT5A LAMP1

2.15e-047962GO:0001912
GeneOntologyBiologicalProcessregulation of natural killer cell mediated immunity

STAT5A LAMP1

2.21e-048062GO:0002715
GeneOntologyBiologicalProcesspositive regulation of cell killing

STAT5A LAMP1

2.67e-048862GO:0031343
GeneOntologyBiologicalProcesspositive regulation of B cell activation

TNFSF13B STAT5A

3.45e-0410062GO:0050871
GeneOntologyBiologicalProcesslymphocyte homeostasis

TNFSF13B STAT5A

3.73e-0410462GO:0002260
GeneOntologyBiologicalProcessnatural killer cell mediated cytotoxicity

STAT5A LAMP1

3.80e-0410562GO:0042267
GeneOntologyBiologicalProcessnatural killer cell mediated immunity

STAT5A LAMP1

4.09e-0410962GO:0002228
GeneOntologyBiologicalProcessregulation of leukocyte mediated cytotoxicity

STAT5A LAMP1

5.29e-0412462GO:0001910
GeneOntologyBiologicalProcessnatural killer cell activation

STAT5A LAMP1

5.29e-0412462GO:0030101
GeneOntologyBiologicalProcesspositive regulation of T cell proliferation

TNFSF13B STAT5A

5.38e-0412562GO:0042102
GeneOntologyBiologicalProcessregulation of cell killing

STAT5A LAMP1

7.43e-0414762GO:0031341
GeneOntologyBiologicalProcesspositive regulation of lymphocyte mediated immunity

STAT5A LAMP1

7.73e-0415062GO:0002708
GeneOntologyBiologicalProcessleukocyte homeostasis

TNFSF13B STAT5A

8.04e-0415362GO:0001776
GeneOntologyBiologicalProcessregulation of B cell activation

TNFSF13B STAT5A

9.12e-0416362GO:0050864
GeneOntologyBiologicalProcesspositive regulation of lymphocyte proliferation

TNFSF13B STAT5A

9.91e-0417062GO:0050671
GeneOntologyBiologicalProcesspositive regulation of mononuclear cell proliferation

TNFSF13B STAT5A

1.03e-0317362GO:0032946
GeneOntologyBiologicalProcesspositive regulation of leukocyte mediated immunity

STAT5A LAMP1

1.05e-0317562GO:0002705
GeneOntologyBiologicalProcessleukocyte mediated cytotoxicity

STAT5A LAMP1

1.20e-0318762GO:0001909
GeneOntologyBiologicalProcesspositive regulation of leukocyte proliferation

TNFSF13B STAT5A

1.25e-0319162GO:0070665
GeneOntologyBiologicalProcesspositive regulation of immune response

TNFSF13B STAT5A LAMP1

1.25e-0384563GO:0050778
GeneOntologyBiologicalProcessB cell differentiation

TNFSF13B STAT5A

1.38e-0320162GO:0030183
GeneOntologyBiologicalProcessregulation of lymphocyte mediated immunity

STAT5A LAMP1

1.83e-0323262GO:0002706
GeneOntologyBiologicalProcesslymphocyte activation

TNFSF13B STAT5A LAMP1

1.90e-0397663GO:0046649
GeneOntologyBiologicalProcessregulation of T cell proliferation

TNFSF13B STAT5A

1.90e-0323662GO:0042129
GeneOntologyBiologicalProcessregulation of immune response

TNFSF13B STAT5A LAMP1

2.57e-03108563GO:0050776
GeneOntologyBiologicalProcessT cell proliferation

TNFSF13B STAT5A

2.81e-0328862GO:0042098
GeneOntologyBiologicalProcesspositive regulation of T cell activation

TNFSF13B STAT5A

2.85e-0329062GO:0050870
GeneOntologyBiologicalProcessregulation of lymphocyte proliferation

TNFSF13B STAT5A

3.06e-0330162GO:0050670
GeneOntologyBiologicalProcessregulation of mononuclear cell proliferation

TNFSF13B STAT5A

3.16e-0330662GO:0032944
GeneOntologyBiologicalProcesscell killing

STAT5A LAMP1

3.18e-0330762GO:0001906
GeneOntologyBiologicalProcessregulation of leukocyte mediated immunity

STAT5A LAMP1

3.22e-0330962GO:0002703
GeneOntologyBiologicalProcessleukocyte activation

TNFSF13B STAT5A LAMP1

3.33e-03118663GO:0045321
GeneOntologyBiologicalProcesspositive regulation of immune effector process

STAT5A LAMP1

3.39e-0331762GO:0002699
GeneOntologyBiologicalProcesspositive regulation of leukocyte cell-cell adhesion

TNFSF13B STAT5A

3.39e-0331762GO:1903039
GeneOntologyBiologicalProcessregulation of leukocyte proliferation

TNFSF13B STAT5A

3.71e-0333262GO:0070663
GeneOntologyBiologicalProcesspositive regulation of immune system process

TNFSF13B STAT5A LAMP1

3.80e-03124263GO:0002684
GeneOntologyBiologicalProcessB cell activation

TNFSF13B STAT5A

3.91e-0334162GO:0042113
GeneOntologyBiologicalProcesscell activation

TNFSF13B STAT5A LAMP1

4.88e-03135663GO:0001775
PathwayPID_ERA_GENOMIC_PATHWAY

STAT5A CALCOCO1

4.20e-046472M200
PathwayWP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2

TNFSF13B STAT5A

5.61e-047472M45517
Pubmed

Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.

STAT5A TET1

1.04e-0737229235481
Pubmed

Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation.

STAT5A LAMP1

5.93e-06197228067668
InteractionEPAS1 interactions

STAT5A TET1 LAMP1

2.12e-0517373int:EPAS1
GeneFamilyADAM metallopeptidase domain containing|CD molecules

TNFSF13B LAMP1

4.54e-0339452471
CoexpressionSHIN_B_CELL_LYMPHOMA_CLUSTER_2

TNFSF13B STAT5A

2.83e-053172M1384
CoexpressionSHIN_B_CELL_LYMPHOMA_CLUSTER_2

TNFSF13B STAT5A

3.02e-053272MM585
CoexpressionFIGUEROA_AML_METHYLATION_CLUSTER_4_UP

CALCOCO1 LAMP1

3.75e-0411272M2170
CoexpressionTABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING

CALCOCO1 LAMP1

4.30e-0412072MM3710
CoexpressionGSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN

TNFSF13B DDX59

9.00e-0417472M381
CoexpressionGSE37532_WT_VS_PPARG_KO_LN_TREG_UP

TET1 CALCOCO1

9.21e-0417672M8952
CoexpressionGSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP

TNFSF13B LAMP1

1.06e-0318972M4933
CoexpressionGSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN

TNFSF13B STAT5A

1.15e-0319772M8227
CoexpressionGSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP

CALCOCO1 LAMP1

1.16e-0319872M8162
CoexpressionGSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN

DDX59 STAT5A

1.17e-0319972M6538
CoexpressionGSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN

TNFSF13B CALCOCO1

1.17e-0319972M8709
CoexpressionGSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP

STAT5A LAMP1

1.17e-0319972M7655
CoexpressionGSE14350_IL2RB_KO_VS_WT_TREG_UP

TNFSF13B DDX59

1.17e-0319972M3421
CoexpressionGSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN

TNFSF13B CALCOCO1

1.17e-0319972M4331
CoexpressionGSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP

TNFSF13B TET1

1.19e-0320072M9289
CoexpressionGSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP

TET1 CALCOCO1

1.19e-0320072M9203
CoexpressionGSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN

TET1 LAMP1

1.19e-0320072M8618
CoexpressionGSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP

STAT5A CALCOCO1

1.19e-0320072M9171
CoexpressionGSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN

TNFSF13B CALCOCO1

1.19e-0320072M6247
CoexpressionGSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP

TNFSF13B KIAA1549

1.19e-0320072M6268
CoexpressionGSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP

CALCOCO1 LAMP1

1.19e-0320072M7665
CoexpressionGSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP

STAT5A TET1

1.19e-0320072M6996
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-3|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

KIAA1549 TET1

1.21e-04109725d194bf95eb777fb4d01bbe5b1639f17ea1bc11a
ToppCell343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells)

DDX59 TET1

1.80e-04133728ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TNFSF13B LAMP1

2.64e-0416172c5d9d47dcedfbb1ac77f4afaf860ae4d9f26fd3f
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TNFSF13B LAMP1

2.64e-0416172b14a83ad07a7acb07c766aa862b527698976b6fc
ToppCellfacs-Brain_Myeloid-Cerebellum_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TNFSF13B LAMP1

2.64e-04161725c762609531a7c5505aa5637abf8e0311568d7fd
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TNFSF13B LAMP1

2.64e-041617226c0d876339bfd34d9a43af5b9fb08f50526f2c9
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-1|TCGA-Ovary / Sample_Type by Project: Shred V9

KIAA1549 TET1

2.77e-04165722ca1154a8692af311d99a4d3aa2f2ac3d23a4310
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TNFSF13B LAMP1

2.81e-04166724ab1959c526c2fd83077fc03e4de207f34841a19
ToppCelldroplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAT5A CALCOCO1

2.88e-0416872de1042267407719f19eb3f580a5df0c9cd0e8273
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIAA1549 TET1

3.12e-0417572bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNFSF13B STAT5A

3.15e-041767276fdf211bce101e83a27d822cb399487bd107027
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TNFSF13B LAMP1

3.87e-04195725a7c74f96f213c504abd65e751800da7e03e47d9
ToppCellCV-Mild-0|Mild / Virus stimulation, Condition and Cluster

CALCOCO1 LAMP1

3.87e-04195722ffb9a9b6143bb404fe454cd939b573252bba6e9
ToppCellLPS_anti-TNF|World / Treatment groups by lineage, cell group, cell type

TNFSF13B LAMP1

3.95e-04197727768e613fa48a6ec4a3902559310b51345a7fe91
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KIAA1549 LAMP1

3.99e-04198720d9d401190792fd61434f1b82548253187d805f0
Drugfenarimol

CALCOCO1 LAMP1

1.37e-045972CID000043226
DrugAC1L1BB2

STAT5A CALCOCO1

2.72e-048372CID000001361
DrugPrestwick_517

TNFSF13B STAT5A

4.44e-0410672CID000003804
DrugNSC145391

TNFSF13B STAT5A

9.95e-0415972CID000286683
Drugwortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA

CALCOCO1 LAMP1

1.33e-03184721081_UP
DrugLY 294002; Up 200; 10uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.37e-03187725233_UP
Drugwortmannin; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA

CALCOCO1 LAMP1

1.40e-0318972911_UP
Drugradicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.42e-03190726979_UP
DrugPyrimethamine [58-14-0]; Down 200; 16uM; HL60; HG-U133A

CALCOCO1 LAMP1

1.42e-03190721974_DN
DrugBacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; HL60; HT_HG-U133A

STAT5A LAMP1

1.44e-03192721337_UP
Drugpioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.44e-03192726898_UP
DrugMeclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; HL60; HT_HG-U133A

STAT5A LAMP1

1.46e-03193721341_UP
DrugIopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.47e-03194723527_DN
Drug(R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.47e-03194726794_DN
DrugDirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.47e-03194722863_DN
DrugAG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A

CALCOCO1 LAMP1

1.49e-03195726557_UP
DrugAcenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A

CALCOCO1 LAMP1

1.49e-03195725878_UP
DrugGuanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A

STAT5A LAMP1

1.50e-03196723171_UP
DrugRetrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.50e-03196722784_UP
DrugPregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.50e-03196724802_DN
DrugNifedipine [21829-25-4]; Up 200; 11.6uM; HL60; HT_HG-U133A

STAT5A LAMP1

1.50e-03196721856_UP
DrugMethoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.50e-03196725007_DN
Drug16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A

CALCOCO1 LAMP1

1.50e-03196726562_DN
Drug(-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA

CALCOCO1 LAMP1

1.50e-0319672982_DN
Drug5255229; Up 200; 13uM; MCF7; HT_HG-U133A_EA

CALCOCO1 LAMP1

1.50e-0319672833_UP
DrugAmphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.50e-03196725404_DN
DrugPhenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; HL60; HT_HG-U133A

STAT5A LAMP1

1.50e-03196722537_DN
DrugGraveoline [485-61-0]; Down 200; 14.4uM; HL60; HT_HG-U133A

STAT5A CALCOCO1

1.50e-03196722179_DN
DrugFluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.50e-03196727333_UP
DrugMefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A

CALCOCO1 LAMP1

1.50e-03196721821_DN
DrugNetilmicin sulfate [56931-57-2]; Down 200; 2.8uM; HL60; HT_HG-U133A

STAT5A CALCOCO1

1.50e-03196722963_DN
DrugHomatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A

CALCOCO1 LAMP1

1.52e-03197721806_DN
DrugTrimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.52e-03197725479_DN
DrugConessine [546-06-5]; Up 200; 11.2uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.52e-03197722792_UP
DrugMyricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.52e-03197723270_DN
DrugCefuroxime sodium salt [56238-63-2]; Down 200; 9uM; HL60; HT_HG-U133A

STAT5A LAMP1

1.52e-03197722526_DN
DrugLevopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.52e-03197725503_DN
DrugVancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; HL60; HT_HG-U133A

STAT5A LAMP1

1.52e-03197722498_DN
DrugPicotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.52e-03197726787_DN
DrugEtofylline [519-37-9]; Down 200; 17.8uM; PC3; HT_HG-U133A

CALCOCO1 LAMP1

1.52e-03197722093_DN
DrugGliquidone [33342-05-1]; Down 200; 7.6uM; HL60; HT_HG-U133A

STAT5A LAMP1

1.52e-03197723126_DN
DrugPhenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; HL60; HG-U133A

CALCOCO1 LAMP1

1.52e-03197721602_DN
DrugAsiaticoside [16830-15-2]; Down 200; 4.2uM; HL60; HT_HG-U133A

STAT5A LAMP1

1.54e-03198722943_DN
DrugL(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.54e-03198726497_DN
Drugclotrimazole; Down 200; 50uM; MCF7; HT_HG-U133A_EA

CALCOCO1 LAMP1

1.54e-0319872905_DN
DrugTrolox [53188-07-1]; Down 200; 16uM; PC3; HT_HG-U133A

CALCOCO1 LAMP1

1.54e-03198727304_DN
DrugAmikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A

CALCOCO1 LAMP1

1.54e-03198725314_DN
DrugRiluzole hydrochloride; Up 200; 14.8uM; MCF7; HT_HG-U133A

STAT5A LAMP1

1.54e-03198724689_UP
DrugMesalamine [89-57-6]; Down 200; 26.2uM; PC3; HT_HG-U133A

CALCOCO1 LAMP1

1.55e-03199725888_DN
DrugPrednisone [53-03-2]; Down 200; 11.2uM; PC3; HG-U133A

CALCOCO1 LAMP1

1.55e-03199721897_DN
Drug2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane

STAT5A LAMP1

1.66e-0320672ctd:C404910
Diseaseurate measurement, bone density

TNFSF13B DDX59

8.60e-0361972EFO_0003923, EFO_0004531
Diseasemonocyte percentage of leukocytes

TNFSF13B CALCOCO1

1.18e-0273172EFO_0007989
DiseaseMalignant neoplasm of breast

DDX59 STAT5A

2.46e-02107472C0006142

Protein segments in the cluster

PeptideGeneStartEntry
NVSRLEGDDNPVQLI

KIAA1549

1226

Q9HCM3
ILVQGQEVTRPIIDF

DDX59

191

Q5T1V6
LQGIQLNTILPDARD

LAMP1

301

P11279
DTLGQAQQRVAELEP

CALCOCO1

326

Q9P1Z2
PQDRAQATQLLEGLV

STAT5A

51

P42229
EDNRSLGVIPQDEQL

TET1

1691

Q8NFU7
GDELQLAIPRENAQI

TNFSF13B

256

Q9Y275